OTCMKTS:RTOKY

Rentokil Initial Price Target, Predictions & Analyst Ratings

$42.36
-0.70 (-1.63 %)
(As of 09/23/2021 12:00 AM ET)
Add
Compare
Today's Range
$42.36
$43.00
50-Day Range
$35.90
$43.06
52-Week Range
$32.42
$43.06
Volume19,564 shs
Average Volume36,824 shs
Market Capitalization$15.75 billion
P/E Ratio43.22
Dividend Yield0.58%
Beta0.77

Rentokil Initial (OTCMKTS:RTOKY) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analyst Rating Consensus

Hold
Based on 11 Analyst Ratings

Analyst Price Target Consensus

$0.00

High PT$0.00
Average PT$0.00
Low PT$0.00
TypeCurrent
9/24/20 to 9/24/21
1 Month Ago
8/25/20 to 8/25/21
3 Months Ago
6/26/20 to 6/26/21
1 Year Ago
9/25/19 to 9/24/20
Consensus Rating
Hold
Hold
Hold
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
7 Buy rating(s)
6 Buy rating(s)
5 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
1 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Price Target UpsideN/AN/AN/AN/A
Get Rentokil Initial Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for RTOKY and its competitors with MarketBeat's FREE daily newsletter.


Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Rentokil Initial (OTCMKTS:RTOKY) vs. Its Competitors

TypeRentokil InitialBusiness Services CompaniesS&P 500
Consensus Rating Score
2.45
2.64
2.56
Consensus RatingHoldBuyBuy
Price Target Upside43.38% Upside7.82% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
206
56.59%
Underperform Votes
158
43.41%
Avg. Outperform Votes
182
63.64%
Avg. Underperform Votes
104
36.36%
Avg. Outperform Votes
829
69.49%
Avg. Underperform Votes
364
30.51%

Rentokil Initial (OTCMKTS:RTOKY) Analyst Ratings History

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/4/2021Deutsche Bank Aktiengesellschaft
Reiterated RatingBuy
7/30/2021Barclays
Reiterated RatingOverweight
7/30/2021Royal Bank of Canada
Reiterated RatingOutperform
7/14/2021Berenberg Bank
Reiterated RatingSell
3/29/2021BNP Paribas
UpgradeNeutral ➝ Outperform
3/29/2021Exane BNP Paribas
UpgradeNeutral ➝ Outperform
3/10/2021UBS Group
Reiterated RatingSell
3/5/2021Morgan Stanley
Reiterated RatingOverweight
3/4/2021Peel Hunt
UpgradeHold
1/14/2021JPMorgan Chase & Co.
Reiterated RatingOverweight
10/5/2020The Goldman Sachs Group
DowngradeBuy ➝ Neutral
6/22/2020Credit Suisse Group
UpgradeNeutral ➝ Outperform
3/19/2020HSBC
DowngradeBuy ➝ Hold
2/24/2020Jefferies Financial Group
UpgradeHold ➝ Buy
2/1/2019Citigroup
UpgradeNeutral ➝ Buy
(Data available from 9/24/2016 forward. View 10+ years of historical ratings with our analyst ratings screener.)
speech bubbles
speech bubbles











Rentokil Initial (OTCMKTS:RTOKY) Analyst Ratings Frequently Asked Questions

What is Rentokil Initial's consensus rating?

According to the issued ratings of 11 analysts in the last year, the consensus rating for Rentokil Initial stock is Hold based on the current 2 sell ratings, 2 hold ratings and 7 buy ratings for RTOKYthe . Learn more on RTOKY's analyst rating history

Do Wall Street analysts like Rentokil Initial more than its competitors?

Analysts like Rentokil Initial stock less than the stock of other Business Services companies. The consensus rating for Rentokil Initial is Hold while the average consensus rating for business services companies is Buy. Learn more on how RTOKY compares to other companies

Do MarketBeat users like Rentokil Initial more than its competitors?

MarketBeat users like Rentokil Initial stock less than the stock of other Business Services companies. 56.59% of MarketBeat users gave Rentokil Initial an outperform vote while business services companies recieve an average of 63.64% outperform votes by MarketBeat users.

What analysts cover Rentokil Initial?

Rentokil Initial has been rated by Barclays, Berenberg Bank, Deutsche Bank Aktiengesellschaft, and Royal Bank of Canada in the past 90 days.

This page was last updated on 9/24/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.